HOME
CONTACT US

Who We Are
Leadership
Pipeline
Investors & Media

Who We Are
Leadership
Pipeline
Investors & Media

Notice of Proposed Settlement of Stockholder Litigation. Click here for information.

Search:

SEC Filings

OTCQB: INTI

PRICE:

Stock Info

OTCQB: INTI OTCQB: HPPI

OTCQB: INTI OTCQB: HPPI

YearCalendar Year 2019 Calendar Year 2018 Calendar Year 2017 Calendar Year 2016 Calendar Year 2015 Calendar Year 2014 Calendar Year 2013 Calendar Year 2012 Calendar Year 2011 Calendar Year 2010 Calendar Year 2009 Calendar Year 2008 Calendar Year 2007 Calendar Year 2006 Calendar Year 2005 Calendar Year 2004 Calendar Year 2003 Calendar Year 2002 Calendar Year 2001 Calendar Year 2000 Calendar Year 1999 Calendar Year 1998 Calendar Year 1997

ViewAll Filings Annual Filings Quarterly Filings Current Filings Registration Statements Section 16 Mergers & Acquisitions Proxy & Information Statements Other

Form	Description	Date	Format

Get Important News and Updates by Email

* Required Fields

* First Name

* Last Name

* Email

4905 Westshore Blvd.
Tampa, FL 33611

Our Mission

Inhibitor Therapeutics, Inc. (“INHIBITOR”) is a pharmaceutical development company focused on developing and commercializing innovative therapies based on already approved active pharmaceutical ingredients for novel, clinically valuable, and patent-protected indications. Our lead product is itraconazole for a hereditary, cancer syndrome (Gorlin’s syndrome) which is an orphan disease.

Home
Who We Are
Pipeline
Investors & Media
Contact Us
Terms of Use and Privacy Policy

Copyright 2023 Inhibitor Therapeutics, Inc.